publisher of Phosphodiesterase-5 inhibition and Cardioprotection in Type 2 Diabetes. 43-59. 2017 Phosphodiesterse-5 inhibition with Tadalafil attenuates detrimental proteomic changes in type 2 diabetic myocardium. 87-104. 2014
